- Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?
-
Hoffmann M, Jones CB, Sietsema D
- KMID: 2382951
- Asian Spine J.
- 2016 Jun;10(3):457-464.
- doi: 10.4184/asj.2016.10.3.457
STUDY DESIGN: Single center retrospective cohort analysis. PURPOSE: The goal was to evaluate the influence of varying amount of recombinant human bone morphogenetic protein 2 (rhBMP-2) per level on fusion rates... -
- CITED
-
- Close
- SHARE
-
- Close
